miR-1226-5p is involved in radioresistance of colorectal cancer by activating M2 macrophages through suppressing IRF1

Jae Yeon Choi,Hyun Jeong Seok,Dong Hyeon Lee,Junhye Kwon,Ui Sup Shin,Incheol Shin,In Hwa Bae
DOI: https://doi.org/10.1186/s12967-024-05797-1
IF: 8.44
2024-10-31
Journal of Translational Medicine
Abstract:Although the representative treatment for colorectal cancer (CRC) is radiotherapy, cancer cells survive due to inherent radioresistance or resistance acquired after radiation treatment, accelerating tumor malignancy and causing local recurrence and metastasis. However, the detailed mechanisms of malignancy induced after radiotherapy are not well understood. To develop more effective and improved radiotherapy and diagnostic methods, it is necessary to clearly identify the mechanisms of radioresistance and discover related biomarkers.
medicine, research & experimental
What problem does this paper attempt to address?